AR008638A1 - Utilizacion de un inhibidor de la actividad del acido retinoico en una composicion cosmetica o para la preparacion de una composicion farmaceutica - Google Patents
Utilizacion de un inhibidor de la actividad del acido retinoico en una composicion cosmetica o para la preparacion de una composicion farmaceuticaInfo
- Publication number
- AR008638A1 AR008638A1 ARP970104308A ARP970104308A AR008638A1 AR 008638 A1 AR008638 A1 AR 008638A1 AR P970104308 A ARP970104308 A AR P970104308A AR P970104308 A ARP970104308 A AR P970104308A AR 008638 A1 AR008638 A1 AR 008638A1
- Authority
- AR
- Argentina
- Prior art keywords
- acid
- benzoic
- benzoic acid
- tetrahydro
- tetramethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cultivation Receptacles Or Flower-Pots, Or Pots For Seedlings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Utilizacion de un inhibidor de la actividad del ácido retinoico en una composicion cosmética o para la preparacion de una composicion farmacéutica,caracterizada porque el inhibidor de la actividad del ácido retinoico o la composicion farmacéutica están destinados a favorecer la cicatrizacion, enparticular la cicatrizacion cutánea. El inhibidor de la actividad del ácido retinoico puede ser un antagonista del ácido retinoico que preferentemente seselecciona entre los siguientes compuestos: -ácido 4-[7-(1-adamantil)-6- metoxietoximetoxi-2-naftil]benzoico, -ácido 4-{[5,6-dihidro-5,5-dimetil-8-(4-metilfenil)-2-naftalenil]etinil}benxoico, -ácido(E)-4-[2-(4,4-dimetil-7- -heptiloxi-1,1-dioxo-3,4-dihidro-2H-1-benzotiopiran--6-il)propenil]benzoico, --ácido 4-[4,5,7,8,9,10-hexahidro-7,7,10,10-tetrametil-1-(3-piridilmetil)an-tra[ 1,2--b]pirrol-3-il]benzoico, -ácido 4-[4,5,7,8,9,10-hexahidro-7,7,10,10-tetrametil-1-(3-piridilmetil)tio-antra[1,2--b]pirrol--3-il]benzoico, -ácido 4- [4,5,7,8,9,10-hexahidro-7,7,10,10,-tetrametil-1-(3-piridilmetil)antra[1,2--d]pirazol-3-il]benzoico, -ácido 4-[3-(diamantil)-4-metoxibenzamido]benzoico, -ácido 4-[3-(diamantil)-4-metoxibenzoiloxi]benzoico, -ácido 4-(N-fenil-5,6,7,8-tetrahidro 5,5,8,8-tetrametilnafto [2,3-d]imidazol-2-il)benzoico, -ácido 4- (N- bencil-5,6,7,8-tetrahidro-5,5,8,8-tetrametilnafto[2,3-d]imidazol-2-il)benzoico,-ácido 4-(5H-7,8,9,10-tetrahidro-5,7,7,10,10-pentametilbenceno[c]-nafto[2,3--b] [1,4]diazepin-3-il)benzoico, -ácido4-[1-(1-metoxi-2,2,2-trifluoroetil)-5,6,7,8-tetrahidro-5,5,8,8-tetrametil-3--antracenil]benzoico, ácido 4-(5,5-dimetil-8- fenil-5,6-dihidro-naftalen-2-iletinil)benzoico, -ácido 4-(5,5-dimetil-8-p-tolil-5,6-dihidro-naftalen-2-iletinil)benzoico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9611511A FR2753627B1 (fr) | 1996-09-20 | 1996-09-20 | Utilisation des inhibiteurs de l'activite de l'acide retinoique pour favoriser la cicatrisation |
Publications (1)
Publication Number | Publication Date |
---|---|
AR008638A1 true AR008638A1 (es) | 2000-02-09 |
Family
ID=9495934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970104308A AR008638A1 (es) | 1996-09-20 | 1997-09-19 | Utilizacion de un inhibidor de la actividad del acido retinoico en una composicion cosmetica o para la preparacion de una composicion farmaceutica |
Country Status (14)
Country | Link |
---|---|
US (1) | US5973007A (es) |
EP (1) | EP0874626B1 (es) |
JP (1) | JPH11500464A (es) |
AR (1) | AR008638A1 (es) |
AT (1) | ATE285761T1 (es) |
AU (1) | AU707390B2 (es) |
BR (1) | BR9709154A (es) |
CA (1) | CA2236309A1 (es) |
DE (1) | DE69732092D1 (es) |
FR (1) | FR2753627B1 (es) |
MX (1) | MX9803995A (es) |
NZ (1) | NZ330401A (es) |
WO (1) | WO1998011886A1 (es) |
ZA (1) | ZA978400B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6436993B1 (en) * | 1999-07-13 | 2002-08-20 | The Salk Institute For Biological Studies | Use of RAR antagonists as modulators of hormone mediated processes |
US6713515B2 (en) | 2000-09-13 | 2004-03-30 | Bristol Myers Squibb Company | Retinoic acid receptor antagonists as promoters of angiogenesis |
JP4473491B2 (ja) * | 2002-05-28 | 2010-06-02 | 株式会社資生堂 | 毛穴縮小剤 |
US7105566B2 (en) * | 2002-10-22 | 2006-09-12 | Allergan, Inc. | Methods of treatment during vascular procedures |
AU2003302070A1 (en) * | 2002-11-15 | 2004-06-15 | Galderma Research And Development, S.N.C. | USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFBeta |
FR2847167A1 (fr) * | 2002-11-15 | 2004-05-21 | Galderma Res & Dev | UTILISATION D'UN ANTAGONISTE DES RECEPTEURS RARs POUR POTENTIALISER L'ACTION DU TGFb |
US20070299041A1 (en) * | 2004-05-26 | 2007-12-27 | Cedars-Sinai Medical Center | Induction of innate immunity by vitamin d3 and its analogs |
US20070049579A1 (en) * | 2005-03-04 | 2007-03-01 | Ryozo Nagai | Medicament having neovascularization promoting action |
DK1764411T3 (da) | 2005-07-26 | 2013-11-04 | Kao Corp | Alkalisk xylanase |
US20080027031A1 (en) * | 2006-03-08 | 2008-01-31 | Kinemed, Inc. | Retinoids and Related Compounds for the Treatment of Neuroinflammatory Conditions, Diseases and Disorders |
FR2910320B1 (fr) | 2006-12-21 | 2009-02-13 | Galderma Res & Dev S N C Snc | Emulsion comprenant au moins un retinoide et du peroxyde de benzole |
FR2910321B1 (fr) | 2006-12-21 | 2009-07-10 | Galderma Res & Dev S N C Snc | Gel creme comprenant au moins un retinoide et du peroxyde de benzole |
FR2931661B1 (fr) | 2008-05-30 | 2010-07-30 | Galderma Res & Dev | Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide. |
TW201930340A (zh) | 2017-12-18 | 2019-08-01 | 美商尼恩醫療公司 | 新抗原及其用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ237003A (en) * | 1990-02-12 | 1992-12-23 | Squibb & Sons Inc | A bandage comprising a retinoid in or on the skin contacting surface |
FR2663850B1 (fr) * | 1990-07-02 | 1994-01-14 | Gird Galderma | Composition pharmaceutique ou cosmetique contenant en association un retinouide et un sterol. |
CA2093577C (en) * | 1992-05-07 | 2006-01-03 | Michael Klaus | Alkyl or alkoxy substituted s-heterocyclic retinoids |
DK0638071T3 (da) * | 1992-12-28 | 1997-10-27 | Eisai Co Ltd | Heterocykliske carboxylsyrederivater, der bindes til retenoidreceptorer (RAR) |
FR2713640B1 (fr) * | 1993-12-15 | 1996-01-05 | Cird Galderma | Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations. |
CA2138000A1 (en) * | 1994-01-03 | 1995-07-04 | John E. Starrett, Jr. | Retinoid-like compounds |
US5807900A (en) * | 1995-03-31 | 1998-09-15 | Hoffmann-La Roche, Inc. | Method for identifying compounds having increased activity for the repair of skin photodamage |
FR2735371B1 (fr) * | 1995-06-19 | 1997-07-18 | Cird Galderma | Procede pour identifier des composes antagonistes des recepteurs rars |
US5808124A (en) * | 1996-06-21 | 1998-09-15 | Allergan | O- or S-substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
-
1996
- 1996-09-20 FR FR9611511A patent/FR2753627B1/fr not_active Expired - Fee Related
-
1997
- 1997-09-17 BR BR9709154A patent/BR9709154A/pt not_active IP Right Cessation
- 1997-09-17 US US09/068,956 patent/US5973007A/en not_active Expired - Fee Related
- 1997-09-17 CA CA002236309A patent/CA2236309A1/fr not_active Abandoned
- 1997-09-17 DE DE69732092T patent/DE69732092D1/de not_active Expired - Lifetime
- 1997-09-17 NZ NZ330401A patent/NZ330401A/xx unknown
- 1997-09-17 EP EP97919115A patent/EP0874626B1/fr not_active Expired - Lifetime
- 1997-09-17 AU AU43061/97A patent/AU707390B2/en not_active Ceased
- 1997-09-17 JP JP10514348A patent/JPH11500464A/ja active Pending
- 1997-09-17 WO PCT/FR1997/001641 patent/WO1998011886A1/fr active IP Right Grant
- 1997-09-17 AT AT97919115T patent/ATE285761T1/de not_active IP Right Cessation
- 1997-09-18 ZA ZA9708400A patent/ZA978400B/xx unknown
- 1997-09-19 AR ARP970104308A patent/AR008638A1/es not_active Application Discontinuation
-
1998
- 1998-05-20 MX MX9803995A patent/MX9803995A/es not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ330401A (en) | 1999-05-28 |
CA2236309A1 (fr) | 1998-03-26 |
DE69732092D1 (de) | 2005-02-03 |
BR9709154A (pt) | 1999-08-03 |
AU707390B2 (en) | 1999-07-08 |
EP0874626B1 (fr) | 2004-12-29 |
WO1998011886A1 (fr) | 1998-03-26 |
EP0874626A1 (fr) | 1998-11-04 |
ZA978400B (en) | 1998-03-26 |
AU4306197A (en) | 1998-04-14 |
ATE285761T1 (de) | 2005-01-15 |
JPH11500464A (ja) | 1999-01-12 |
FR2753627A1 (fr) | 1998-03-27 |
US5973007A (en) | 1999-10-26 |
FR2753627B1 (fr) | 2003-02-21 |
MX9803995A (es) | 1998-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR008638A1 (es) | Utilizacion de un inhibidor de la actividad del acido retinoico en una composicion cosmetica o para la preparacion de una composicion farmaceutica | |
UY24816A1 (es) | Sulfonamidas agonistas de prostaglandinas para la prevención y restauración de la masa ósea | |
AR009398A1 (es) | Utilizacion de inhibidores de la actividad del acido retinoico para el tratamiento de pieles sensibles y/o los danos agudos inducidos por los rayos u.v. | |
AR008878A1 (es) | Antagonistas del receptor de vitronectina, un metodo para su preparacion, una composicion farmaceutica que los contiene y el uso de las mismas para la preparacion de un medicamento. | |
UY26253A1 (es) | Derivados del triazol y del imidazol | |
ES2117150T3 (es) | Derivados tipo 25-acido carboxilico en la serie de la vitamina d, preparados farmaceuticos que contienen dichos derivados y su empleo en la preparacion de medicamentos. | |
GB2193961A (en) | 3-hydroxybenzo(b)thiophene-2-carboxamides | |
KR20220044558A (ko) | 칸나비디올을 포함하는 외용 제제, 조성물의 제조 방법 및 이의 용도 | |
AU1438699A (en) | Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals | |
EP0910410A1 (en) | Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds | |
ES2142030T3 (es) | Nuevos compuestos espiro-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
Soliven et al. | Arachidonic acid and its metabolites increase Cai in cultured rat oligodendrocytes | |
Hartman et al. | Comparison of antiinflammatory and antiallergic drugs in the melittin-and D49 PLA2-induced mouse paw edema models | |
AR002704A1 (es) | 2-(2-n-alcoxifenil)-purin-6-onas 9-sustituidas, procedimiento para su preparacion, composiciones farmaceuticas que las contienen y su uso parapreparar composiciones farmaceuticas. | |
KR20010043147A (ko) | 멜라닌 생성을 촉진하는 화합물의 확인을 위한 분석법 및그 분석법에 의해 확인되는 레티노이드류 화합물 | |
ES2145563T3 (es) | Nuevos derivados de la imidazolina con una afinidad para los receptores imidazolinicos. | |
PE20050393A1 (es) | Compuestos de benzopirano para uso en el tratamiento y la prevencion de afecciones relacionadas con la inflamacion | |
ES2143833T3 (es) | Acidos y esteres de la diosmetina y composiciones farmaceuticas que los contienen. | |
ES2179523T3 (es) | Metodo para aumentar la biodisponibilidad de la fexofenadina y sus derivados. | |
MX9300423A (es) | Derivados heterociclicos. | |
US5827500A (en) | Process for identifying RAR-receptor-antagonist compounds | |
ES2172023T3 (es) | Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
PE12098A1 (es) | Composiciones y metodos para tratar transtornos respiratorios | |
AR031681A1 (es) | Compuestos relacionados con el acido 15-hidroxieicosatetraenico y sus metodos de uso, composicion para el tratamiento del ojo seco y otros trastornos y el uso de dicha composicion para la manufactura de un medicamento | |
SV1997000033A (es) | Derivados de acido 4-arilbutirico sustituido como inhibisor de matriz de metaloproteasa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |